Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 0 | 0 | 3,500 | 0 | 68 |
| Cost of Goods | 30 | N/A | 1,575 | N/A | 100 |
| Gross Profit | -30 | N/A | 1,925 | N/A | -32 |
| Operating Expenses | 13,209 | 11,334 | 13,054 | 12,038 | 13,004 |
| Operating Income | -13,209 | -11,334 | -10,554 | -12,038 | -12,936 |
| Interest Expense | 109 | 105 | 103 | 101 | 178 |
| Other Income | -3,273 | -397 | -5,997 | 3,032 | 5,993 |
| Pre-tax Income | -16,591 | -11,836 | -16,654 | -9,107 | -7,121 |
| Net Income Continuous | -16,591 | -11,836 | -16,654 | -9,107 | -7,121 |
| Net Income | $-16,591 | $-11,836 | $-16,654 | $-9,107 | $-7,121 |
| EPS Basic Total Ops | -0.59 | -0.48 | -0.92 | -0.54 | 0.63 |
| EPS Basic Continuous Ops | -0.59 | -0.48 | -0.92 | -0.54 | 0.46 |
| EPS Diluted Total Ops | -0.59 | -0.48 | -0.92 | -0.54 | 0.63 |
| EPS Diluted Continuous Ops | -0.59 | -0.48 | -0.92 | -0.54 | 0.46 |
| EBITDA(a) | $-12,488 | $-10,583 | $-9,716 | $-11,150 | $-11,927 |